PL2744913T3 - Metodologia prognostyczna - Google Patents

Metodologia prognostyczna

Info

Publication number
PL2744913T3
PL2744913T3 PL12753796T PL12753796T PL2744913T3 PL 2744913 T3 PL2744913 T3 PL 2744913T3 PL 12753796 T PL12753796 T PL 12753796T PL 12753796 T PL12753796 T PL 12753796T PL 2744913 T3 PL2744913 T3 PL 2744913T3
Authority
PL
Poland
Prior art keywords
prognostic
methodology
prognostic methodology
Prior art date
Application number
PL12753796T
Other languages
English (en)
Inventor
Duncan Baird
Chris Pepper
Christopher Fegan
Original Assignee
Univ College Cardiff Consultants Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ College Cardiff Consultants Ltd filed Critical Univ College Cardiff Consultants Ltd
Publication of PL2744913T3 publication Critical patent/PL2744913T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12753796T 2011-08-15 2012-08-09 Metodologia prognostyczna PL2744913T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1113968.0A GB201113968D0 (en) 2011-08-15 2011-08-15 Prognostic methadology
PCT/GB2012/051936 WO2013024264A1 (en) 2011-08-15 2012-08-09 Prognostic methodology
EP12753796.7A EP2744913B1 (en) 2011-08-15 2012-08-09 Prognostic methodology

Publications (1)

Publication Number Publication Date
PL2744913T3 true PL2744913T3 (pl) 2016-04-29

Family

ID=44764459

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12753796T PL2744913T3 (pl) 2011-08-15 2012-08-09 Metodologia prognostyczna

Country Status (14)

Country Link
US (1) US20150292021A1 (pl)
EP (1) EP2744913B1 (pl)
JP (2) JP6178313B2 (pl)
CN (1) CN103748237A (pl)
AU (1) AU2012296717B2 (pl)
BR (1) BR112014003247A2 (pl)
CA (1) CA2845047C (pl)
DK (1) DK2744913T3 (pl)
ES (1) ES2556606T3 (pl)
GB (1) GB201113968D0 (pl)
PL (1) PL2744913T3 (pl)
PT (1) PT2744913E (pl)
RU (1) RU2014103536A (pl)
WO (1) WO2013024264A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201418144D0 (en) * 2014-10-14 2014-11-26 Univ Cardiff High throughput sequencing
US11156599B2 (en) 2015-03-19 2021-10-26 The Johns Hopkins University Assay for telomere length regulators
GB201818792D0 (en) 2018-11-19 2019-01-02 Telonostix Ltd Compounds for telomere length-related treatment of cancer
EP4202057A1 (en) * 2021-12-23 2023-06-28 European Molecular Biology Laboratory Detection of telomere fusion events

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2309350T3 (es) 2002-07-11 2008-12-16 Advanced Bio Surfaces, Inc. Metodo y equipo para artroplastia interposicional.
US9169516B2 (en) * 2003-01-24 2015-10-27 University Of Utah Research Foundation Methods of predicting mortality risk by determining telomere length
CA2547901A1 (en) 2006-06-14 2007-12-14 University College Cardiff Consultants Limited Chronic lymphocytic leukaemia

Also Published As

Publication number Publication date
DK2744913T3 (en) 2016-01-25
BR112014003247A2 (pt) 2017-03-01
NZ620854A (en) 2015-02-27
AU2012296717B2 (en) 2016-12-22
EP2744913B1 (en) 2015-11-18
GB201113968D0 (en) 2011-09-28
AU2012296717A1 (en) 2014-02-27
JP6562970B2 (ja) 2019-08-21
ES2556606T3 (es) 2016-01-19
PT2744913E (pt) 2016-02-11
JP6178313B2 (ja) 2017-08-09
CN103748237A (zh) 2014-04-23
JP2014524251A (ja) 2014-09-22
RU2014103536A (ru) 2015-09-27
CA2845047C (en) 2020-03-24
US20150292021A1 (en) 2015-10-15
WO2013024264A1 (en) 2013-02-21
CA2845047A1 (en) 2013-02-21
JP2017176188A (ja) 2017-10-05
EP2744913A1 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
DK3424953T3 (en) Terapeutiske antistoffer
DK2691417T4 (en) Antistof fc-varianter
GB201112665D0 (en) Data anonymisation
EP2755962A4 (en) AZAINDAZOLES
EP2754063A4 (en) EXTENSIBILITY OF THE SMB2 PROTOCOL
EP2776444A4 (en) dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
GB201301300D0 (en) No details
GB201104556D0 (en) Biomarkers
EP2685340A4 (en) DATA LINE
DK2770906T3 (en) Applanationstonometer
PL2744913T3 (pl) Metodologia prognostyczna
ZA201403228B (en) Heterocyclypyri(mi)dinylpyrazole
GB201109024D0 (en) Can
GB201100001D0 (en) TidySqueeze2
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5026P (en) Goldstrike Agapanthus inapertus
AU5031P (en) BESYS Beschorneria yuccoides
AU5171P (en) Sunparamiho Mandevilla xamabilis
GB201121280D0 (en) Biomarker
GB201107838D0 (en) Biomarker
GB201103906D0 (en) Novel methodology
GB201119196D0 (en) Biomarkers
GB201119847D0 (en) Well testing
GB201200015D0 (en) Information disclosure